Back to News
Market Impact: 0.35
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
Source: zacks.com
Corporate EarningsCompany FundamentalsHealthcare & BiotechAnalyst Estimates
AngioDynamics beat first-quarter earnings estimates as revenue rose 6.9%, supported by strong Med Tech growth and robust Auryon and NanoKnife sales. The company also reported margin expansion.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
ANGO0.70
More News
- Rising fuel costs slashed Delta’s profit outlook despite strong demand
- What's behind the recovery rally in tech stocks — plus, Elon Musk's very good week
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- OpenAI's revenue scare, Delta earnings, what investors think of a Starbucks-Chipotle deal and more in Morning Squawk
- Delta Cuts Profit Outlook as Surging Fuel Costs Tighten Grip